Physician profile
Ashley K Williams
NPI 1225525827
$1,666.70
in general payments reported to CMS, 2019-2025
26 companies · $679 in 2025
The $679 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.66 · 2022: $60.66 · 2023: $643 · 2024: $268 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,519.39 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $283.01 | 2023-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $233.28 | 2023-2025 | |
| Minerva Surgical, INC | $139.97 | 2025 | |
| Exeltis, USA INC. | $136.98 | 2022-2025 | Slynd, Twirla |
| Abbvie INC. | $108.64 | 2022-2023 | Lo Loestrin Fe |
| Biogen, INC. | $100.98 | 2025 | Zurzuvae |
| Pfizer INC. | $71.52 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $64.74 | 2021-2025 | |
| Millicent US INC | $64.51 | 2024-2025 | Femlyv, Intrarosa |
| Merck Sharp & Dohme LLC | $49.15 | 2023-2025 | Gardasil 9, Gardasil |
| Medtronic, INC. | $38.34 | 2024 | Interstim |
| Coopersurgical, INC. | $38.00 | 2025 | Endosee, Sos |
| Organon LLC | $36.78 | 2023-2024 | Nexplanon |
| Amgen INC. | $33.90 | 2025 | Evenity, Prolia |
| Sage Therapeutics, LLC | $33.03 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $31.66 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Ironshore Pharmaceuticals INC. | $28.25 | 2024 | |
| Solventum Corporation | $26.82 | 2025 | Prevena |
| Meditrina | $21.06 | 2023-2025 | |
| Dexcom, INC. | $20.77 | 2023 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $20.11 | 2024 | Myfembree |
| Baxter Healthcare | $18.72 | 2025 | Perclot |
| Hydrofera LLC | $18.50 | 2025 | Sorbact Other |
| Therapeuticsmd, INC. | $16.80 | 2022 | |
| Agile Therapeutics, INC. | $16.62 | 2023 | Twirla |
| Lsi Solutions INC | $14.56 | 2023 | Running Device, Ti Knot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.